Immediate Impact
1 from Science/Nature 54 standout
Citing Papers
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
2023 Standout
Surgical Site Infection Prevention
2023 Standout
Works of Daniel H. Benckart being referenced
Effect of Glucagon-Like Peptide-1 (GLP-1) on Glycemic Control and Left Ventricular Function in Patients Undergoing Coronary Artery Bypass Grafting
2007
Recent experience with major sternal wound complications
1990
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Daniel H. Benckart | 832 | 599 | 330 | 35 | 1.3k | |
| Aamir Shah | 930 | 916 | 358 | 43 | 1.6k | |
| Anne T. Rogers | 689 | 640 | 255 | 43 | 1.2k | |
| Peter Tassani | 546 | 630 | 241 | 37 | 1.3k | |
| C. Harold Mielke | 377 | 508 | 200 | 36 | 1.5k | |
| Yue Zhao | 643 | 855 | 191 | 48 | 1.6k | |
| G. Matheis | 774 | 570 | 272 | 64 | 1.5k | |
| G. William‐Olsson | 369 | 461 | 277 | 79 | 1.0k | |
| Brian M. Fabri | 592 | 742 | 134 | 32 | 989 | |
| Charissa E. van den Brom | 345 | 468 | 250 | 58 | 1.2k | |
| S Westaby | 656 | 473 | 222 | 38 | 1.1k |
All Works
Loading papers...